Atria Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$462K Buy
34,150
+5,744
+20% +$68.7K ﹤0.01% 1568
2026
Q1
$170K Buy
28,406
+16,915
+147% +$127K ﹤0.01% 1995
2025
Q4
$82.4K Sell
11,491
-2,456
-18% -$19.4K ﹤0.01% 2012
2025
Q3
$149K Buy
+13,947
New +$137K ﹤0.01% 1973

Other funds holding OGN

Atria Investments's OGN Position: Q2 2026 in Review

Atria Investments increased its Organon & Co (OGN) stake by 20% in Q2 2026, buying an estimated $68.7K and bringing the position to 34,150 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

Atria Investments first reported a position in OGN in Q3 2025 and has held it in 4 quarters since. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Atria Investments held 34,150 shares of Organon & Co worth $462K as of Q2 2026.
  • Atria Investments bought 5,744 Organon & Co shares in Q2 2026, an estimated $68.7K.
  • Organon & Co made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1568 holding.
  • Atria Investments first reported a position in Organon & Co in Q3 2025 and has held it in 4 quarters since.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.